Henry Schein Inc
(FRA:HS2)
€
64.18
-2.8 (-4.18%)
Market Cap: 7.85 Bil
Enterprise Value: 10.51 Bil
PE Ratio: 27.87
PB Ratio: 2.43
GF Score: 83/100 Henry Schein Inc at Leerink Partners Global Healthcare Conference Transcript
Feb 27, 2019 / 04:00PM GMT
Release Date Price:
€51.21
(-1.35%)
David M. Larsen
SVB Leerink LLC, Research Division - MD, Healthcare Information Technology and Distribution
All right, let's get started. I'm Dave Larsen, a healthcare IT distribution analyst here for SVB Leerink. We're delighted to have Steve Paladino of Henry Schein with us. Thanks, Steve, for joining; and Carolynne Borders is here as well. So I appreciate it. Thanks.
Steven Paladino
Henry Schein, Inc. - Executive VP, CFO & Executive Director
Thank you.
Questions & Answers
David M. Larsen
SVB Leerink LLC, Research Division - MD, Healthcare Information Technology and Distribution
All right. Let's get started. Why don't you talk about the Animal Health spin? So what was the rationale behind that? Why did you spin that off? That was a pretty good grower for you guys. Maybe just your thoughts on that would be great.
Steven Paladino
Henry Schein, Inc. - Executive VP, CFO & Executive Director
Sure. Well, first, it was a bit of a historic year for us in
Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis | |
30-Year Financial on one screen | |
All-in-one Stock Screener with unlimited filters | |
Customizable Stock Dashboard | |
Real Time Insider Trading Transactions | |
8,000+ Institutional investors’ 13F holdings | |
Powerful Excel Add-in and Google sheets Add-on | |
All data downloadable | |
Quick customer support | |
And much more... |
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot